From Financialisation to Innovation in UK Big Pharma
This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Online |
| Jazyk: | angličtina |
| Vydáno: |
Cambridge University Press
2024
|
| Témata: | |
| On-line přístup: | ONIX_20240819_9781009278140_103 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky: From Financialisation to Innovation in UK Big Pharma
- Chapter 5 FinTechs, BigTechs and structural changes in capital markets
- Mastering Your Entrepreneurial Journey
- Big Data in Organizations and the Role of Human Resource Management
- Introduction to Quantum Computing for Business
- Private Sector Development in an Emerging World
- Fashion and Environmental Sustainability